Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Forodesine in CLL
NCT00640523Phase 2Completed
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Mar 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of forodesine in chronic lymphocytic leukemia (CLL), sponsored by BioCryst Pharmaceuticals, Inc.. Started Mar 2008; status: completed.
02
Drugs
forodesine
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00640523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640523.